Search Results

0 results for 'Valeant Pharmaceuticals International Inc'

You can use to get even better search results
February 20, 2014 |

Actavis Buys Forest Labs for $25B

Mergers and acquisitions across the state, including a $25 billion buy for Actavis, and $425 million purchase for Valeant.
1 minute read
January 10, 2014 |

Leading M&A Transactions-Target or Acquirer Based in N.J.-2013

Leading M&A transactions with the target or acquirer based in N.J. in 2013.
11 minute read
December 27, 2013 |

Mergers & Acquisitions

New Jersey Mergers & Acquisitions.
1 minute read
December 24, 2013 |

Cold Remedy: Am Law 100 Firms Load Up on Pharma M&A

Pharmaceutical M&A got a late-year shot in the arm, with nearly $10 billion in deals involving major industry players like AstraZeneca and Bayer as 2013 came to a close. A bevy of Am Law 100 firms led by Covington, Kirkland, Sullivan & Cromwell, Skadden, and Weil have grabbed lead roles on the transactions.
11 minute read
December 16, 2013 |

Valeant Buying Solta Medical for About $250M

Valeant Pharmaceuticals International Inc. is buying Solta Medical Inc. for about $250 million.
1 minute read
December 02, 2013 |

Big Deals

Applied Materials / Tokyo Electron; Koch Industries / Molex; Ares/CPPIB / Neiman Marcus; Regency Energy / PVR
10 minute read
November 18, 2013 |

Geithner Joins Warburg in Shift to Buyouts From Bailouts

As he starts his career on Wall Street next year, former Treasury Secretary Timothy Geithner has chosen a buyout firm, New York-based Warburg Pincus LLC.
6 minute read
June 27, 2013 |

Big Deals

Valeant/Bausch & Lomb; Actavis/Warner Chilcott; BMC Software buyout; Inergy/Crestwook Midstream Partners
10 minute read
September 01, 2010 |

Canadian Big Deals

Biovail/Valeant; Sinopec/Syncrude; CIBC/Canadian MasterCard
7 minute read
September 04, 2012 |

Four Am Law 100 Firms Advise on Valeant's $2.6 Billion Skin Care Deal

Canadian health care company Valeant Pharmaceuticals International will pay $2.6 billion to acquire Medicis Pharmaceutical Corporation in a deal that bolsters Valeant's position in the skin care products market. Sullivan & Cromwell, Skadden, Latham, and Weil Gotshal all landed roles on the transaction.
3 minute read

Resources

  • Good Legal Technology is Good Business: A Case for Bringing Employment Issues In-House

    Brought to you by LexisNexis®

    Download Now

  • Insights and Strategies for Effective Succession Planning in AM Law 100 Firms

    Brought to you by Gallagher

    Download Now

  • State AI Legislation Is on the Move in 2024

    Brought to you by LexisNexis®

    Download Now

  • 2024 ESI Risk Management & Litigation Readiness Report

    Brought to you by Pagefreezer

    Download Now